Next Generation Sequencing Market - SINGLE USER

The Next Generation Sequencing (NGS) Industry is a multibillion market which consists of multitudinous companies involved in the manufacturing of instruments, kits & consumables, and development of software to bolster the NGS workflow.

Advancements in sequencing chemistry, molecular biology, and technical engineering over the years have profoundly increased the sequencing efficiency while decreasing the cost. Impressive progress in these fields have paved the way for development of massively parallel, high-throughput sequencing technology, known as Next Generation Sequencing (NGS).
The purpose of this study is to gain a holistic view of the NGS market in terms of various influencing factors, such as recent trends, technological advancements, role of service providers, and funding scenario in the market. The scope of this report constitutes of an in-depth study of the global next generation sequencing market, including a thorough analysis of the products across different regions. The market has been segmented into ‘technology’, ‘product’, ‘application’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.
This research report aims at answering various aspects of the global NGS market with the help of key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key ecosystem players and key strategies & developments taking place in this market. In addition, the report includes market dynamics (market drivers, opportunities and challenges) and industry analysis.
The research study considers the market share analysis for a comprehensive understanding of the global NGS market and assesses the factors governing the same. Funding scenarios, Porter’s five force analysis, opportunity matrix, detailed product mapping and R&D analysis have been included in the report.
The market by region has been further sub-segmented in countries and in each sub-segments, key market trends, list of key players, and recent developments were listed.
The answers to the following key questions can be derived from this report:
• What are the major market drivers, challenges and opportunities in the global next generation sequencing market?
• How did the next generation sequencing market evolve and what is its scope in the future?
• What are the key developmental strategies which are being implemented by the key players to stand out in this market? Among these strategies which strategy is currently dominating the market?
• What is the total addressable market (TAM), segmental addressable market (SAM) and the potential market opportunity of the global next generation sequencing market?
• What is the market share of different leading segments and sub-segments of the market for the years 2017 and 2024?
• How will each segment of the global next generation sequencing market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2024?
• Who are the key players dominating the global next generation sequencing market and their respective share in the market?
• Who are the key players dominating the next generation sequencing market, in different product segments namely instruments and kits & reagents?
• What are the influencing factors that may affect the market share of the key players?
• What is the perception of investors worldwide towards the market and which type of companies are receiving significant investments?
• Who are the leading service providers of sequencing tests and what is their contribution to the market? What is the concentration of service providers worldwide?
• How the market has been segmented on the basis of technology? Which technology is leading and and what is its share in the market?
• Which geographical location will contribute to the highest sales of sequencing products and how regions have been further segmented into countries?
• Who are the key players dominating the next generation sequencing market, in different regions namely North America, Europe, and Asia Pacific and their respective share?
• What is the market share of companies by different segments, namely products, technology, and geography, along with the global share analysis of market?
• What is the investors’ perception towards the market?
• What is the frequency of service providers’ presence in different geographical regions?
The key players which have been contributing significantly to the NGS market include 10x Genomics, Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, GenapSys, Inc., Illumina, Inc., New England Biolabs, Inc., NuGEN Technologies Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Partek, Inc., PerkinElmer, Inc., QIAGEN, and Thermo Fisher Scientific, among others.
Executive Summary
1 Report Scope & Methodology
1.1 Scope of the Report
1.2 Market Segmentation
1.3 Research Methodology
1.4 Data Triangulation
1.5 Key Data Points From Secondary Sources
1.6 Secondary Data Sources
1.7 Key Data Points from Primary Sources
1.8 Top-Down Approach (Segmental Analysis)
1.9 Bottom-Up Approach (Segmental Analysis)
1.10 Assumptions and Limitations
1.11 Data and Prediction Modelling
2 Market Overview
2.1 Introduction
2.2 History of Next Generation Sequencing
3 Market Dynamics
3.1 Promoting and Inhibiting Factors of the Next Generation Sequencing Market Growth
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Challenges
4 Competitive Landscape
4.1 Key Developments and Strategies
4.2 Market Share Analysis by Company
4.3 Market Share by Companies, by Instruments
4.4 Market Share by Companies, by Kits & Consumables
4.5 Industry Attractiveness
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Power of Buyer
4.5.3 Threat of New Entrants
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 Funding Scenario
5.1 Key Players of the Market are Investing Substantial Amounts in Bioinformatics Start-ups
6 Industry Insights
6.1 Legal Requirements and Regulations
6.2 List of Regulatory Bodies
6.3 Role of Service Providers in Next Generation Sequencing Market
7 Global Next Generation Sequencing Market by Product
7.1 Introduction
7.2 Instruments
7.2.1 Integrated Workflow Instruments
7.2.2 Sequencing Instruments
7.2.3 Library Preparation Instruments
7.3 Kits & Consumables
7.3.1 Library Preparation Kits
7.3.2 Target Enrichment Kits
7.3.3 Sequencing Kits
7.3.4 Multiuse Kits
7.4 Software
8 Global Next Generation Sequencing Market by Technology
8.1 Introduction
8.2 Ion Torrent Semiconductor Sequencing
8.3 Reversible Terminator Sequencing
8.4 Single Molecule Real Time Sequencing
8.5 Nanopore Sequencing Technologies
8.6 Other Technologies
9 Global Next Generation Sequencing Market by Application
9.1 Introduction
9.2 Pharmaceuticals
9.3 Diagnostics
9.4 Agricultural and Animal Research
9.5 Forensics
9.6 Others
10 Global Next Generation Sequencing Market by Geography
10.1 Global Insights
10.2 Analysis
10.3 North America
10.3.1 U.S.
10.3.2 Canada
10.4 Europe
10.4.1 U.K.
10.4.2 Germany
10.4.3 France
10.4.4 Spain
10.4.5 The Netherlands
10.4.6 Rest of the Europe
10.5 Asia Pacific
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 Australia
10.5.5 Rest of Asia Pacific
10.6 Rest of the World
11 Company Profiles
11.1 10x Genomics
11.2 Agilent Technologies, Inc.
11.3 BGI
11.4 bioMerieux SA
11.5 Bio-Rad Laboratories, Inc.
11.6 Eurofins Scientific
11.7 F. Hoffmann-La Roche AG
11.8 GATC Biotech AG.
11.9 GenapSys, Inc.
11.10 GENEWIZ
11.11 Illumina, Inc.
11.12 New England Biolabs, Inc.
11.13 NuGEN Technologies Inc.
11.14 Oxford Nanopore Technologies Limited
11.15 Pacific Biosciences of California, Inc.
11.16 Partek, Inc.
11.17 PerkinElmer, Inc.
11.18 QIAGEN
11.19 Thermo Fisher Scientific
List of Tables
1 Product Launch and Product Up-gradation
2 Acquisitions
3 Join Ventures, Partnerships, Agreements, and Collaborations
4 Business Expansion
5 Approvals
6 Others
7 Funding Scenario NGS Market
8 List of Regulatory Bodies
9 Country Wise Service Providers
10 Global Next Generation Sequencing Market Revenue, by Products, $Million (2016-2024)
11 Next Generation Sequencing Market Revenue, by Technology, $Million (2016 – 2024)
12 Ion Torrent Semiconductor Sequencing Products
13 List of Service Providers, by Country
14 Reversible Terminator Sequencing Products
15 Reversible Terminator Sequencing Country Wise Service Providers
16 Single Molecule Real Time Sequencing Products
17 Single Molecule Real Time Sequencing Country Wise Service Providers
18 Global Next Generation Sequencing Market Revenue, by Applications, $Million (2016 -2024)
19 Overview: 10x Genomics
20 Overview: Agilent Technologies, Inc.
21 Overview: BGI
22 Overview: bioMerieux SA
23 Overview: Bio-Rad Laboratories, Inc.
24 Overview: Eurofins Scientific
25 Overview: F. Hoffmann-La Roche AG
26 Overview: GATC Biotech AG.
27 Overview: GenapSys, Inc.
28 Overview: GENEWIZ
29 Overview: Illumina, Inc.
30 Overview: New England Biolabs, Inc.
31 Overview: NuGEN Technologies Inc.
32 Overview: Oxford Nanopore Technologies Limited
33 Overview: Pacific Biosciences of California, Inc.
34 Overview: Partek, Inc.
35 Overview: PerkinElmer, Inc.
36 Overview: QIAGEN
37 Overview: Thermo Fisher Scientific
List of Figures
1 Emerging Fields Based on NGS
2 Global Next Generation Sequencing Market Share, by Company (2016)
3 Leading Service Providers
4 Global Next Generation Sequencing Market Revenue (2016-2024)
5 Global Next Generation Sequencing Market Share, by Product (2016)
6 Global Next Generation Sequencing Market Share, by Product (2024)
7 Global Next Generation Sequencing Market, by Technology (2016)
8 Global Next Generation Sequencing Market, by Technology (2024)
9 Global Next generation Sequencing Market, by Application (2016)
10 Global Next Generation Sequencing Market, by Application (2024)
11 Global Next Generation Sequencing Market, by Region
12 Next Generation Sequencing Market Segmentation
13 Research Methodology
14 Applications of Next Generation Sequencing
15 Evolution of Next Generation Sequencing Market
16 Share of Key Developments and Strategies
17 Global Next Generation Sequencing Market Share, by Company (2015)
18 Global Next Generation Sequencing Market Share, by Company (2016)
19 Global Next Generation Sequencing Market, by Company, by Instruments (2015)
20 Global Next Generation Sequencing Market Share, by Company, by Instruments (2016)
21 Global Next Generation Sequencing Market Share, by Company, by Kits & Consumables (2015)
22 Global Next Generation Sequencing Market Share, by Company, by Kits & Consumables (2016)
23 Porter’s Five Forces Analysis
24 Level of NGS Service Provider Presences
25 Global NGS Market Share, by Product, 2016
26 Global Next Generation Sequencing Market, by Instruments (2016-2024)
27 Global Next Generation Sequencing Market, by Integrated Workflow Instruments (2016-2024)
28 Global Next Generation Sequencing Market, by Sequencing Instruments (2016-2024)
29 Global Next Generation Sequencing Market, by Library Preparation Instruments (2016-2024)
30 Global Next Generation Sequencing Market, by Kits & Consumables (2016-2024)
31 Global Next Generation Sequencing Market, by Library Preparation Kits (2016-2024)
32 Global Next Generation Sequencing Market, Target Enrichment Kits (2016-2024)
33 Global Next generation Sequencing Market, by Sequencing Kits (2016-2024)
34 Global Next Generation Sequencing Market, by Multiuse Kits (2016-2024)
35 Global Next Generation Sequencing Market, by Software (2016-2024)
36 Global NGS Market Share, by Technology, 2016
37 Next Generation Sequencing Market, by Sequencing Type
38 Global Next Generation Sequencing Market Share, by Technology, by Company (2016)
39 Global Next Generation Sequencing Market, by Ion Torrent Semiconductor Sequencing Technology (2016-2024)
40 Global Next Generation Sequencing Market Share, by Technology, by Company (2016)
41 Global NGS Market, by Reversible Terminator Sequencing (2016-2024)
42 Next Generation Sequencing Market Share, by Technology, by Company (2016)
43 Global NGS Market, by Single Molecule Real Time Sequencing (2016-2024)
44 Global NGS Market, by Nanopore Sequencing Technologies (2016-2024)
45 Global NGS Market, by Other Technologies (2016-2024)
46 Global NGS Market Share, by Application, 2016
47 Global NGS Market Revenue, by Pharmaceuticals (2016-2024)
48 Global NGS Market Revenue, by Diagnostics (2016-2024)
49 Global NGS Market Revenue, by Agricultural and Animal Research (2014-2016)
50 Global NGS Market Revenue, by Forensic (2016-2024)
51 Global NGS Market Revenue, by Other Applications (2016-2024)
52 Global Next Generation Sequencing Market, by Region
53 Global Next Generation Sequencing Market Revenue, by Region (2016-2024)
54 Next Generation Sequencing Market Share, by Region (2016)
55 Next Generation Sequencing Market Share, by Region (2024)
56 North America Next Generation Sequencing Market Revenue(2016-2024)
57 North America Next Generation Sequencing Market Revenue, by Product (2016-2024)
58 North America Next Generation Sequencing Market, by Company (2015)
59 North America Next Generation Sequencing Market, by Company (2016)
60 North America Next Generation Sequencing Market Revenue, by Country (2016-2024)
61 U.S. Next Generation Sequencing Market Revenue (2016-2024)
62 Canada Next Generation Sequencing Market Revenue (2016-2024)
63 Europe Next Generation Sequencing Market Revenue (2016-2024)
64 Europe Next Generation Sequencing Market Revenue, by Product (2016-2024)
65 Europe Next Generation Sequencing Market Share, by Company (2015)
66 Europe Next Generation Sequencing Market Share, by Company (2016)
67 Europe Next Generation Sequencing Market Revenue, by Country (2016-2024)
68 U.K. Next Generation Sequencing Market Revenue (2016-2024)
69 Germany Next Generation Sequencing Market Revenue (2016-2024)
70 France Next Generation Sequencing Market Revenue (2016-2024)
71 Spain Next Generation Sequencing Market Revenue (2016-2024)
72 The Netherlands Next Generation Sequencing Market Revenue (2016-2024)
73 Next Generation Sequencing Market Revenue, in Rest of the Europe (2016-2024)
74 Asia Pacific Next Generation Sequencing Market Revenue (2016-2024)
75 Asia Pacific Next Generation Sequencing Market Revenue, by Product (2016-2024)
76 Asia Pacific Next Generation Sequencing Market Share, by Company (2015)
77 Asia Pacific Next Generation Sequencing Market Share, by Company (2016)
78 Asia Pacific Next Generation Sequencing Market Revenue, by Country (2016-2024)
79 China Next Generation Sequencing Market Revenue (2016-2024)
80 Japan Next Generation Sequencing Market Revenue (2016-2024)
81 India Next Generation Sequencing Market Revenue (2016-2024)
82 Australia Next Generation Sequencing Market Revenue (2016-2024)
83 Next Generation Sequencing Market Revenue, in Rest of Asia Pacific (2016-2024)
84 Next Generation Sequencing Market Revenue, in Rest of World (2016-2024)
85 Next Generation Sequencing Market Revenue, by Rest of World, by Product (2016-2024)
86 10x Genomics: Product Portfolio
87 10x Genomics: SWOT Analysis
88 Agilent Technologies, Inc.: Product Portfolio
89 Agilent Technologies, Inc.: Overall Financials (2014-2016)
90 Agilent Technologies, Inc.: Revenue by Business Segment (2014-2016)
91 Agilent Technologies, Inc.: Revenue by Region (2014-2016)
92 Agilent Technologies, Inc.: SWOT Analysis
93 BGI: Product Portfolio
94 BGI: SWOT Analysis
95 bioMérieux SA: Overall Financials (2014-2016)
96 bioMérieux SA: Revenue by Business Segment (2014-2016)
97 bioMérieux SA: Revenue by Region (2014-2016)
98 bioMérieux SA: SWOT Analysis
99 Bio-Rad Laboratories, Inc.: Product Portfolio
100 Bio-Rad Laboratories, Inc.: Overall Financials (2014-2016)
101 Bio-Rad Laboratories, Inc.: Net Revenue by Business Segment (2014-2016)
102 Bio-Rad Laboratories, Inc.: Revenue by Region (2014-2016)
103 Bio-Rad Laboratoires, Inc.: SWOT Analysis
104 Eurofins Scientific: Product Portfolio
105 Eurofins Scientific: Overall Financials (2014-2016)
106 Eurofins Scientific: Revenue by Business Segment (2014-2016)
107 Eurofins Scientific: SWOT Analysis
108 F. Hoffmann-La Roche AG: Product Portfolio
109 F. Hoffmann-La Roche AG: Net Revenue (2014-2016)
110 F. Hoffmann-La Roche AG: Revenue by Region (2014-2016)
111 F. Hoffmann-La Roche AG: Revenue by Divisions (2014-2016)
112 F. Hoffmann-La Roche AG: Revenue By Diagnostics Sub-division (2014-2016)
113 F. Hoffmann-La Roche AG: SWOT Analysis
114 GATC Biotech AG.: Product Portfolio
115 GATC Biotech AG.: SWOT Analysis
116 GenapSys, Inc.: SWOT Analysis
117 GENEWIZ: Product Portfolio
118 GENEWIZ: SWOT Analysis
119 Illumina, Inc.: Product Portfolio
120 Illumina, Inc.: Overall Financials (2014-2016)
121 Illumina, Inc.: Net Revenue by Business Segment, (2014-2016)
122 Illumina, Inc.: Revenue by Region, (2014-2016)
123 Illumina, Inc.: SWOT Analysis
124 New England Biolabs, Inc.: Product Portfolio
125 New England Biolabs, Inc.: SWOT Analysis
126 NuGEN Technologies Inc.: Product Portfolio
127 NuGEN Technologies Inc.: SWOT Analysis
128 Oxford Nanopore Technologies Limited: Product Portfolio
129 Oxford Nanopore Technologies Limited: SWOT Analysis
130 Pacific Biosciences of California, Inc.: Product Portfolio
131 Pacific Biosciences of California, Inc.: Overall Financials (2014-2016)
132 Pacific Biosciences of California, Inc.: Net Revenue by Business Segment (2014-2015)
133 Pacific Biosciences, Inc.: Net Revenue by Business Sub-Segment (2014-2016)
134 Pacific Biosciences of California, Inc.: Net Revenue by Region (2014-2015)
135 Pacific Biosciences of California, Inc.: SWOT Analysis
136 Partek, Inc.: Product Portfolio
137 Partek, Inc.: SWOT Analysis
138 PerkinElmer, Inc.: Product Portfolio
139 PerkinElmer, Inc.: Overall Financials (2014-2016)
140 PerkinElmer, Inc.: Net Revenue by Business Segment (2014-2016)
141 PerkinElmer, Inc.: Net Revenue by Region (2014-2016)
142 PerkinElmer, Inc.: SWOT Analysis
143 QIAGEN: Product Portfolio
144 QIAGEN: Overall Financials (2014-2016)
145 QIAGEN: Net Revenue by Business Segment (2014-2016)
146 QIAGEN: Net Revenue by Region (2014-2016)
147 QIAGEN: SWOT Analysis
148 Thermo Fisher Scientific: Product Portfolio
149 Thermo Fisher Scientific: Overall Financials (2014-2016)
150 Thermo Fisher Scientific: Net Revenue by Business Segment (2014-2016)
151 Thermo Fisher Scientific: Net Revenue by Region (2014-2016)
Sanger sequencing technology was utilized for the sequencing of first human genome, which took around 1.5 decades while costing approximately $2.7billion. Advancements in sequencing chemistry, molecular biology, and technical engineering over the years have profoundly increased the sequencing efficiency while decreasing the cost. Impressive progress in these fields have paved the way for development of massively parallel, high-throughput sequencing technology, known as Next Generation Sequencing (NGS). As compared to Sanger sequencing, NGS technology allows sequencing of millions of fragments in a single run, while decreasing the time and cost per run. Till date, progress in NGS technology has decreased the cost of sequencing from $10 million to $1000 and further evolution of this technology is aimed at decreasing the cost of sequencing to $100.
NGS technologies have evolved in terms of high resolution and accuracy, sequencing speed, throughput, and cost-effectiveness in genomic analysis to accelerate biological and biomedical research. The NGS technologies are implemented in several applications namely pharmaceuticals, diagnostics, forensics, agriculture and animal research. Additionally, the double digit growth rate of the NGS market was largely fuelled by the rise in the demand for precision medicine, liquid biopsy tests, and Non-Invasive Prenatal Testing (NIPT), among others.
The purpose of the study is to gain a holistic view of the next generation sequencing market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the technologies allied with the next generation sequencing market. The global next generation sequencing market is segmented in to four different parts namely by product, by technology, by application and by geography. The global market value was estimated using these four different approaches and was validated with one another. These segments are further segmented into several sub-segments to ease the market estimation and to gain holistic view of the market.
The global next generation market was estimated at $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024. The global next generation sequencing market is expected to grow with a double digit compound annual growth rate between the years 2017 and 2024. With substantial increase in the demand for genome mapping programs and diagnostics tests based on sequencing, the NGS market is expected to witness impressive growth and promises to be a lucrative field for investment. Kits & consumables sub segment dominated the product segment of global next generation sequencing market in 2016. However, the software sub segment is expected to witness the highest CAGR in the forecast period from 2017 to 2024.
Additionally, the reversible terminator sequencing technology currently dominates the global NGS market. ,. The emerging technologies such as Nanopore technology is estimated to witness the highest CAGR in the forecast period.
And by application, presently, the pharmaceuticals field makes up the largest dominating share of the global next generation sequencing market and is expected to grow at 11.29% CAGR in the forecast period from 2017 to 2024. However, with the growing demand for non-invasive diagnostic procedures, the diagnostic field is expected to witness an impressive CAGR in the forecast period from 2017 to 2024.
The global next generation sequencing market is segmented by the geographical region into North America, Europe, Asia Pacific and Rest of the World (RoW). North America is a leading contributor to the global next generation sequencing market and contributed 50% of the global market values in 2016. However, Asia Pacific is expected to grow at 17.53% CAGR in the forecast period from 2017 to 2024. Moreover, the Asia Pacific market contributed approximately 13% of total global market value in 2016.
A paradigm shift in the dynamics market is expected in the year 2020 with the introduction of portable technologies in full scale. The leading players in the market are taking the necessary steps to tackle the shift in the dynamics and sustain in the competition. The global next generation sequencing market is majorly dominated by the U.S. players. Companies belonging to the U.S. such as Illumina, Inc. and Thermo Fisher Scientific have been reported to contribute more than 60% of the market value in 2016. The key players which have significant contributions to the NGS market are 10x Genomics, Agilent Technologies, Inc., bioMerieux SA, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, GenapSys, Inc., Illumina, Inc., New England Biolabs, Inc., NuGEN Technologies Inc., Oxford Nanopore Technologies Limited, Pacific Biosciences of California, Inc., Partek, Inc., PerkinElmer, Inc., QIAGEN, and Thermo Fisher Scientific, among others.
The field of service providers for sequencing tests and the applications based on genome sequencing is perceived to be a lucrative business all across the globe. With the impressive rise in demand for sequencing based diagnostics applications namely NIPT and liquid biopsy, the service providing companies have gained popularity and acceptance all across the globe. Additionally, substantial investments are being made in bioinformatics startups and service providing companies. With the growing demand for genome mapping programs, a large pool of genomic data is being generated and key players of the market are seeking help from the bioinformatics startups to meet the market requirement. Service providing companies help in expanding the global reach of key players of the market and also play a significant role in increasing the adoptability of sequencing technologies all across the globe.
Some of the opportunities on which significant work is being carried out presently in the market are hybridization of technologies and development of portable technologies. A best sequencer would be the one with the ability to sequence long reeds, in short run time and with great accuracy. The present available sequencers on the market possess any one of the mentioned features, but not all three. Despite the substantial investments made by the prominent companies to develop the instrument with the features mentioned, it is not expected to be the reality at any time soon. Thus the hybridization of available technologies such as SMRT and reversible semiconductor sequencing technology, is acknowledged to be a promising approach to cater the needs of the market
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Netherlands
Rest of the Europe
Asia Pacific
China
Japan
India
Australia
RoW
Global Next Generation Sequencing, next generation sequencing market , next generation sequencing market, next generation sequencing, next gen sequencing , next generation sequencing market report , ngs report , Ion Torrent Semiconductor Sequencing, ion torrent sequencing , Reversible Terminator Sequencing, Single Molecule Real Time Sequencing, nanopore sequencing , Global Next Generation Sequencing Market Revenue, Global Next Generation Sequencing Market Share, global ngs market share , ngs market share , next generation sequencing market growth, next generation sequencing market size, next generation sequencing services market
Sanger sequencing technology was utilized for the sequencing of the first human genome, which took around 1.5 decades while costing approximately $2.7billion. Advancements in sequencing chemistry, molecular biology, and technical engineering over the years have profoundly increased the sequencing efficiency while decreasing the cost. Impressive progress in these fields has paved the way for the development of massively parallel, high-throughput sequencing technology, known as Next Generation Sequencing (NGS). As compared to Sanger sequencing, NGS technology allows sequencing of millions of fragments in a single run, while decreasing the time and cost per run. Till date, progress in NGS technology has decreased the cost of sequencing from $10 million to $1000 and further evolution of this technology is aimed at decreasing the cost of sequencing to $100.
NGS technologies have evolved in terms of high resolution and accuracy, sequencing speed, throughput, and cost-effectiveness in the genomic analysis to accelerate biological and biomedical research. The NGS technologies are implemented in several applications namely pharmaceuticals, diagnostics, forensics, agriculture and animal research. Additionally, the double-digit growth rate of the NGS market was largely fuelled by the rise in the demand for precision medicine, liquid biopsy tests, and Non-Invasive Prenatal Testing (NIPT), among others.
According to the latest research report by BIS Research, titled ‘Global Next Generation Sequencing (NGS) Market - Analysis and Forecast (2017-2024)’, the global next generation market was estimated at $4.14 billion in 2016 and is estimated to grow over $11.92 billion by 2024. The market is expected to grow with a double-digit compound annual growth rate between the years 2017 and 2024. With a substantial increase in the demand for genome mapping programs and diagnostics tests based on sequencing, the NGS market is expected to witness impressive growth and promises to be a lucrative field for investment. Kits & consumables sub-segment dominated the product segment of global next generation sequencing market in 2016. However, the software sub-segment is expected to witness the highest CAGR in the forecast period from 2017 to 2024.
Additionally, the reversible terminator sequencing technology currently dominates the global NGS market. ,. The emerging technologies such as Nanopore technology is estimated to witness the highest CAGR in the forecast period. And by application, presently, the pharmaceuticals field makes up the largest dominating share of the global next-generation sequencing market and is expected to grow at 11.29% CAGR in the forecast period from 2017 to 2024. However, with the growing demand for non-invasive diagnostic procedures, the diagnostic field is expected to witness an impressive CAGR in the forecast period from 2017 to 2024.
Few Companies Mentioned in the Report:
• 10x Genomics
• Agilent Technologies, Inc.
• BGI
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche AG
• GATC Biotech AG.
• GenapSys, Inc.
• GENEWIZ
• Illumina, Inc.
• New England Biolabs, Inc.
• NuGEN Technologies Inc.
• Oxford Nanopore Technologies Limited
• Pacific Biosciences of California, Inc.
• Partek, Inc.
• PerkinElmer, Inc.
• QIAGEN
• Thermo Fisher Scientific
Key questions addressed in the report:
• What are the major market drivers, challenges, and opportunities in the global next-generation sequencing market?
• How did the next generation sequencing market evolve and what is its scope in the future?
• What are the key developmental strategies which are being implemented by the key players to stand out in this market? Among these strategies which strategy is currently dominating the market?
• What is the total addressable market (TAM), segmental addressable market (SAM) and the potential market opportunity for the global next-generation sequencing market?
• What is the market share of different leading segments and sub-segments of the market for the years 2017 and 2024?
• How will each segment of the global next-generation sequencing market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2024?
• Who are the key players dominating the global next-generation sequencing market and their respective share in the market?
• Who are the key players dominating the next generation sequencing market, in different product segments namely instruments and kits & reagents?
• What are the influencing factors that may affect the market share of the key players?
• What is the perception of investors worldwide towards the market and which type of companies are receiving significant investments?
• Who are the leading service providers of sequencing tests and what is their contribution to the market? What is the concentration of service providers worldwide?
• How has the market been segmented on the basis of technology? Which technology is leading and what is its share in the market?
• Which geographical location will contribute to the highest sales of sequencing products and how regions have been further segmented into countries?
• Who are the key players dominating the next generation sequencing market, in different regions namely North America, Europe, and Asia Pacific and their respective share?
• What is the market share of companies by different segments, namely products, technology, and geography, along with the global share analysis of market?
• What is the investors’ perception towards the market?
• What is the frequency of service providers’ presence in different geographical regions?
10x Genomics
BGI
bioMerieux SA
Bio-Rad Laboratories, Inc.
Eurofins Scientific
F. Hoffmann-La Roche AG
GATC Biotech AG.
GenapSys, Inc.
GENEWIZ
Illumina, Inc.
New England Biolabs, Inc.
NuGEN Technologies Inc.
Oxford Nanopore Technologies Limited
Pacific Biosciences of California, Inc.
Partek, Inc.
PerkinElmer, Inc.
QIAGEN
Thermo Fisher Scientific